Settings8H · net · $10k
LanguageThe language of the site
FundingPeriod funding rates are shown in
UnitsPercent or basis points
CostsCount taker fees and slippage in Net
SizePosition per leg used for Net and slippage
ExchangesWhich exchanges to include everywhere
My profile →
My profile
Backtest 30d
LegExchangePriceFund. /8hEach paymentNext inOIVol 24hLev
LONG118.63+0.0033pay 0.0004% / 1h2m 21s$40K$133K25xLong Injective
SHORT119.01+0.0048get 0.0006% / 1h2m 21s$391K$643K20xShort Popdex
Price gap+0.320%46s
Funding gap+0.0015% /8h

Both sides work: funding pays $0 a day on $10k, and the gap is 0.387% above its 7d average: +$39 more if it goes back.

The two prices were read 46 s apart: part of this gap may be the market moving.

If you open now and hold

on $10k a leg · figures of the last 7D, not a forecast
Funding+$6+0.0015% /8h now · paid +0.059% over the last 6 days (all we have)
Price—spread +0.320%46s now · prices read too far apart to compare
Costs−$550.552% of $10k · taker + slippage, in and out
Result—no pointsneeds both prices read together

Funding history

you earnyou payavg
RANGE STATS · 7D
Average /8h—
Highest—
Lowest—
Paid you—

Short leg rate minus long leg rate, per 8h. Above zero: the pair pays you.

Price spread between the two exchanges

Popdex price against Injectivenow
RANGE STATS · 7D
Now+0.320%
Average—
Range—
Wider than now—

Where the spread has been, last 7D

share of time at each level

Funding on every exchange

/8h

HOOD on 31 exchanges

lowest funding first

Before you open

2 ok · 3 to watch
  • Watch: Thin at this size27.2 / 8.4 bp
    At $10k entering Injective costs 27.2 bp, fee and slippage, 3.3× Popdex’s.
  • Note: Margin at max leverage$400 + $500
    Injective 25x, Popdex 20x. Keep about 2× this so a sharp move doesn’t liquidate one leg.
  • OK: Same payment interval1h / 1h
    Both legs pay at the same time.
    Next 24h at the current rates, on $10k a leg: +$0.44Long Injective: 24 payments, −$1.00; short Popdex: 24 payments, +$1.44.
  • Watch: Prices read 46 s apart+0.320% vs −0.066%
    Part of this gap may be the market moving.
  • Watch: Long leg is thinner$40K vs $391K OI
    Injective sets your exit cost. Check its book before closing.
  • Note: No points program—
    Neither exchange runs points right now.
  • OK: No KYC on either legInjective No · Popdex No
    Both exchanges let you trade without ID.

Profit calculator

both legs, in and out
Position, each leg
Hold for
Orders
Price spread
Funding rate
Funding earned+0.0033%/8h × 21 periods+$6.94
Price spreadprices read too far apart to compare—
Slippage, 4 orderslive order books−$48.73
Fee Injective bp × 2 orders−$0.02
Fee Popdex bp × 2 orders−$6.40
Net · 7 days · $10k−$48.21
price spread not counted: prices read too far apart
Costs to cover0.552%Break-even55.6 days
Slippage: Injective: live order book, 26 min ago; Popdex: live order book, 16 min ago

Cost to enter

taker + slippage from mid, one side
BUY · LONGInjective13.0227.2 bp−$27156.6 bp−$1,56691563.3 bp−$9.16M497812.7 bp−$248.91M
SELL · SHORTPopdex0.848.4 bp−$813.3 bp−$133doesn’t fitdoesn’t fit

Closing costs about the same again.

Alert

HOOD news

posts that mention HOOD or Robinhood Markets, from every exchangeSearch all news →
09-28 18:50AevoOtherbitcoin:native is back near $83k after trading above $86k last week. Whether you trade the continuation or pullback, all options and this week’s Perp Majors count toward the volume requirement for our year-end reward. This week’s Perp Majors include: BTC, ETH, SOL, ZEC, NEAR, HYPE, LIT, SPY, QQQ, HOOD, SNDK, MU, NVDA, TSLA, GOOGL. @aevoxyz on X ↗
09-21 16:05AevoContestbitcoin:native broke $85k, zcash:native crossed $1.5k, and near:native is up 70%+ in 7 days. Trading them adds volume to Aevo’s year-end leaderboard for the projected 808,800 USDC reward. Options count too, as do the other Perp Majors: ETH, SOL, HYPE, LIT, SPY, QQQ, HOOD, SNDK, MU, NVDA, TSLA, GOOGL. @aevoxyz on X ↗
09-21 13:35gTrade (Gains Network)Listingnew market HOOD/USD ($HOOD) seen by our collector
09-19 00:09SoDEXOtherRobinhood (HOOD) shares are up 9.12% today. The company has grown beyond its commission-free trading roots, expanding across options, crypto, retirement products, and subscription services while building a broader retail investing ecosystem. Explore our latest research on Robinhood, its growth strategy, and what could drive the company next: @sodex_official on X ↗
09-18 17:30Vest MarketsOther$COIN is rebounding from Tuesday's Senate defeat of the CLARITY Act, up around 12% on the session. The SEC issued a five-year innovation exemption that allows tokenized versions of U.S. stocks to trade on blockchain venues, with a comment period open. Crypto-linked equities are broadly higher, with $MSTR, $HOOD and $CRCL also up on the session. @VestExchange on X ↗
09-17 09:45RISExOther→ $ARB: → $HOOD: @risextrade on X ↗